RNA, U7 small nuclear 193 pseudogene (RNU7-193P)

RNU7-193P is annotated as a pseudogene of the U7 small nuclear RNA (U7 snRNA) gene family. U7 snRNA itself is a functional non-coding RNA required for the 3'-end processing of replication-dependent histone pre-mRNAs, playing a critical role in histone mRNA maturation and ultimately cell-cycle dependent histone synthesis[1][4][5][6]. However, pseudogenes such as RNU7-193P are nonfunctional, typically the result of retrotransposition or duplication events, and generally do not produce functional RNA or protein products[7][6]. There is no evidence that RNU7-193P has a role as a therapeutic target, a biomarker, or is involved in disease, nor that it interacts with drugs or plays a biological function. Key issue: "RNU7-193P" refers to a pseudogene—that is, a nonfunctional genomic copy—rather than a functional gene/protein/receptor/target. Most biomedical databases do not classify pseudogenes as drug targets or assign them biological function, molecular family, or therapeutic relevance[6][7]. Additional context: Functional U7 snRNA is essential for the processing of histone pre-mRNA but this activity is not associated with pseudogenes such as RNU7-193P[1][4][6]. Hundreds of similar U7 pseudogenes are annotated in the human genome; these are not considered druggable targets, nor do they have a defined physiological or pathological role[6]. "RNU7-193P" is not found in curated lists of drug targets, biomarkers, or critical disease genes. Summary of issues: It is not a valid target for pharmacologic modulation or biomarker use (is_target: false). As a pseudogene, there is no evidence for function, interaction with drugs, or relevance to human disease. The entry is not incorrect in spelling, but is incorrect as a drug target or molecularly functional entity (is_incorrect: true).

Other names

RNU7-193PRNA U7 small nuclear 193 pseudogene